Effect of pegylated interferon therapy on intrahepatic recurrence after curative treatment of hepatitis C virus-related hepatocellular carcinoma-Reference-Cited by-同舟云学术

Effect of pegylated interferon therapy on intrahepatic recurrence after curative treatment of hepatitis C virus-related hepatocellular carcinoma

Published:2010-12-09 Issue:3 Volume:16 Page:210-220
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Hagihara Hiroaki,Nouso Kazuhiro,Kobayashi Yoshiyuki,Iwasaki Yoshiaki,Nakamura Shinichiro,Kuwaki Kenji,Toshimori Junichi,Miyatake Hirokazu,Ohnishi Hideki,Shiraha Hidenori,Yamamoto Kazuhide

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Link

http://link.springer.com/content/pdf/10.1007/s10147-010-0150-x.pdf

Reference41 articles.

1. Tsukuma H, Hiyama T, Tanaka S et al (1993) Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 328:1797–1801

2. Takano S, Yokosuka O, Imazeki F et al (1995) Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients. Hepatology 21:650–655

3. Shiratori Y, Shiina S, Imamura M et al (1995) Characteristic difference of hepatocellular carcinoma between hepatitis B- and C-viral infection in Japan. Hepatology 22:1027–1033

4. Ikeda K, Saitoh S, Tsubota A et al (1993) Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma. Cancer (Phila) 71:19–25

5. Tateishi R, Shiina S, Teratani T et al (2005) Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer (Phila) 103:1201–1209

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Survival and Cancer Risk in the Hepatitis C Virus-Infected Patients After Antiviral Treatment: A Nationwide Cohort Study;Journal of Cancer;2024

2. Impact of Interferon on the Prognosis of Hepatitis C Virus-Related Hepatocellular Carcinoma Patients with a Sustained Virological Response –An Additional Comparison Between Preoperative and Postoperative Sustained Virological Response;The Kurume Medical Journal;2021-03-31

Timing of DAA Initiation After Curative Treatment and Its Relationship with the Recurrence of HCV-Related HCC

;Journal of Hepatocellular Carcinoma;2020-12

4. Clinical outcomes of direct‐acting antiviral treatments for patients with hepatitis C after hepatocellular carcinoma are equivalent to interferon treatment;Hepatology Research;2020-08-03

5. Viral elimination is essential for improving surgical outcomes of hepatitis C virus‐related hepatocellular carcinoma: Multicenter retrospective analysis;Annals of Gastroenterological Surgery;2020-07-23